Overview
Cosmin Lisencu practices practicing medicine in Cluj-napoca, Romania.
Their clinical expertise encompasses Leukemoid Reaction, Colorectal Cancer, Acute Pain, and Breast Cancer.
They are actively involved in clinical research, co-authoring 25 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Cosmin I. Lisencu
Is Cosmin I. Lisencu a top-rated expert for Leukemoid Reaction?
MediFind is an objective health platform that identifies experts based on real-world data. Cosmin I. Lisencu is classified as an Experienced expert for Leukemoid Reaction, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Cosmin I. Lisencu participate in research or clinical trials?
Yes. Cosmin I. Lisencu has published 25 articles and abstracts on conditions like Leukemoid Reaction. You can view a list of Cosmin I. Lisencu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute PainLisencu isExperienced. Learn about Acute Pain.
- Breast CancerLisencu isExperienced. Learn about Breast Cancer.
- Colorectal CancerLisencu isExperienced. Learn about Colorectal Cancer.
- Leukemoid ReactionLisencu isExperienced. Learn about Leukemoid Reaction.